semaglutide and hyperthyroidism Thyroid Medication: Safety and Interactions Combined Treatment of Type 2

A retrospective analysis of 105,000+ patients revealed: 40% lower OSA risk with tirzepatide (Zepbound) or semaglutide (Wegovy) vs non-AOM users Lower OSA incidence: 3.12% vs 12.56% Comparable impact between tirzepatide and semaglutide, with tirzepatide showing a slight edge after 6 months This study highlights the potential for AOMs to address obesity and OSA, supporting broader healthcare value through comorbidity reduction

PharmEasy guides you on the best weight loss patches, their effectiveness, and side effects in detail

Do GLP-1 patches work

Out-of-Pocket Costs Drive Abandonment Especially in Obesity While payer restrictions and coverage gaps contribute to GLP-1 therapy abandonment, out-of-pocket (OOP) costs remain the most consistent and powerful predictor of non-adherence

Getting a flu vaccine while on GLP-1 medications like semaglutide is generally safe, but timing and immune function matter